Call to arrange a consultation
+1 416 777 0888

ViiV Healthcare Company et al. v. JAMP Pharma Corporation

2024
T-938-24
Pending
6(1) PMNOC

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,606,282, 2,967,453, and 3,003,988 (dolutegravir-abacavir-lamivudine).

Counsel to: 
JAMP Pharma Corporation
here.
Arrow down